MCX Q4 Results: Multi Commodity Exchange of India (MCX) reported a consolidated net profit at Rs 530 crore for the March-ended quarter versus Rs 135 crore in the year ago period, implying a 291% YoY surge. The profit after tax (PAT) is attributable to the owners of the company.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,